Picton Mahoney Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-350,000
Closed -$14.7M 514
2023
Q2
$14.7M Buy
+350,000
New +$14.2M 0.64% 36
2022
Q1
Sell
-11,245
Closed -$1.16M 1090
2021
Q4
$1.16M Sell
11,245
-75
-0.7% -$7.2K 0.03% 547
2021
Q3
$990K Buy
+11,320
New +$1.02M 0.04% 508
2020
Q2
Sell
-28,700
Closed -$1.13M 366
2020
Q1
$1.13M Buy
+28,700
New +$1.68M 0.06% 206

Other funds holding SYNH

Picton Mahoney Asset Management's SYNH Position: Q3 2023 in Review

Picton Mahoney Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 350,000 shares — an estimated $14.7M sold.

Picton Mahoney Asset Management first reported a position in SYNH in Q1 2020 and held it in 4 quarters. The position peaked at $14.7M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Picton Mahoney Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 350,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $14.7M.
  • Picton Mahoney Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2020 and held it in 4 quarters.
  • Picton Mahoney Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $14.7M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.